Arcadia Biosciences, Inc. Forecast, price target & analysts
Arcadia Biosciences, Inc. Target price 2024 - Analyst rating & recommendation
Arcadia Biosciences, Inc. Classifications & Recommendation:
Arcadia Biosciences, Inc. Price Target
| Target Price | $9.00 |
| Price | $2.90 |
| Potential |
210.35%
register free of charge
|
| Number of Estimates | 2 |
|
2 Analysts have issued a price target Arcadia Biosciences, Inc. 2025 .
The average Arcadia Biosciences, Inc. target price is $9.00.
This is
210.35%
register free of charge
$12.00
313.79%
register free of charge
$6.00
106.90%
register free of charge
|
|
| A rating was issued by 2 analysts: 2 Analysts recommend Arcadia Biosciences, Inc. to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Arcadia Biosciences, Inc. stock has an average upside potential 2025 of
210.35%
register free of charge
|
Sales and Margin forecast 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 5.33 | 3.69 |
| 46.49% | 30.77% | |
| EBITDA Margin | -241.65% | -140.92% |
| 33.42% | 41.68% |
2 Analysts have issued a sales forecast Arcadia Biosciences, Inc. 2024 . The average Arcadia Biosciences, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Arcadia Biosciences, Inc. 2024 . The average Arcadia Biosciences, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| EV/Sales | negative |
Based on analysts' sales estimates for 2024, the Arcadia Biosciences, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Arcadia Biosciences, Inc....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
